News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Oxtoby Andrew
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| Oxtoby Andrew (Chief Commercial Officer) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 160,000 options to buy
@ $21.82, valued at
$3.5M
Disposed/sold 40,000 restricted stock units
@ $0 |
|
| 03/02/2023 |
4
| Oxtoby Andrew (Chief Commercial Officer) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Granted 160,000 options to buy
@ $21.82, valued at
$3.5M
Granted 40,000 options to buy
@ $0 |
|
| 10/14/2020 |
4
| Oxtoby Andrew (Chief Commercial Officer) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Unknown transaction of 6,345 shares
@ $34.5, valued at
$218.9k
Disposed/sold 20,250 shares
@ $34.5, valued at
$698.6k
Disposed/sold 150,000 options to buy
@ $21.94, valued at
$3.3M
Disposed/sold 67,500 options to buy
@ $23.81, valued at
$1.6M
|
|
| 09/16/2020 |
4
| Oxtoby Andrew (Chief Commercial Officer) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 840 shares
@ $34.25, valued at
$28.8k
|
|
| 05/12/2020 |
4
| Oxtoby Andrew (Chief Commercial Officer) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Granted 2,420 shares
@ $0 |
|
| 03/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2019 |
4
| Oxtoby Andrew (Chief Commercial Officer) has filed a Form 4 on Aimmune Therapeutics, Inc.|
Txns:
| Granted 12,000 shares
@ $0
Granted 150,000 options to buy
@ $21.94, valued at
$3.3M
|
|
| 01/24/2019 |
3
| Oxtoby Andrew (Chief Commercial Officer) has filed a Form 3 on Aimmune Therapeutics, Inc. |
|
|